Published March 20, 2022 | Version v1

Imatinib disassembles the regulatory core of Abelson kinase by binding to its ATP site and not by binding to its myristoyl pocket

  • 1. Biozentrum, University of Basel, CH-4056 Basel, Switzerland
  • 2. Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Hyderabad, Telangana-500037, India

Description

NMR raw 1H-15N TROSY data and processed spectra of a titration of U-15N-labeled Abl83-534 with imatinib presented in the manuscript "Imatinib disassembles the regulatory core of Abelson kinase by binding to its ATP site and not by binding to its myristoyl pocket".

1H-15N TROSY spectra were recorded at molar ratios of 0, 1:10, 3:10, 5:10, 7:10, 1:1, and 3:1 imatinib:Abl83-534 at 303 K on a Bruker Ascend 600-MHz spectrometer equipped with a TCI triple resonance cryoprobe with 140 (15N) × 1024 (1H) complex points and acquisition times of 42 ms (15N) and 48 ms (1H).

Description of files contained in DATA.zip:

  1. A3D.DAT: raw data in NMRPipe format with the 7 titration points stored a subsequent 2D planes
  2. B3D.DAT: processed data in NMRPipe format with the 7 titration points stored a subsequent 2D planes
  3. xy_3D.com: NMRPipe processing script to convert A3D.DAT to B3D.DAT

Notes

This work was supported by the Swiss Cancer League (grant KFS-3603-02-2015 to R.S. and S.G) and the Swiss National Science Foundation (grants 31-149927, 31-173089, and 31-201270 to S.G.).

Files

DATA.zip

Files (5.9 MB)

Name Size Download all
md5:811f9bce3b4f14e1ac2a71cda29faa35
5.9 MB Preview Download